Search for other papers by Robert Rapaport in
Google Scholar
PubMed
Search for other papers by Peter A Lee in
Google Scholar
PubMed
Nemours/DuPont Hospital for Children, Wilmington, Delaware, USA
Search for other papers by Judith L Ross in
Google Scholar
PubMed
Search for other papers by Paul Saenger in
Google Scholar
PubMed
Search for other papers by Vlady Ostrow in
Google Scholar
PubMed
Search for other papers by Giuseppe Piccoli in
Google Scholar
PubMed
developed as practical tools to estimate the response to GH therapy for the diagnosis of growth hormone deficiency (GHD) ( 19 ), SGA ( 20 ) and ISS ( 21 ). The non-interventional American Norditropin Studies: Web-Enabled Research (ANSWER) Program was
Search for other papers by Urszula Smyczyńska in
Google Scholar
PubMed
Search for other papers by Joanna Smyczyńska in
Google Scholar
PubMed
Department of Paediatric Endocrinology, Medical University of Lodz, Lodz, Poland
Search for other papers by Maciej Hilczer in
Google Scholar
PubMed
Search for other papers by Renata Stawerska in
Google Scholar
PubMed
Search for other papers by Ryszard Tadeusiewicz in
Google Scholar
PubMed
Department of Endocrinology and Metabolic Diseases, Medical University of Lodz, Lodz, Poland
Search for other papers by Andrzej Lewiński in
Google Scholar
PubMed
Introduction Growth hormone (GH) therapy is widely approved in children with short stature caused by GH deficiency (GHD). It has also been documented that GH therapy may be beneficial in children with idiopathic short stature (ISS); however
EndoERN, APHP Consortium Pitie Salpetriere Hospital, Necker Hospital, Paris, France
Search for other papers by Nathalie Ly in
Google Scholar
PubMed
EndoERN, APHP Consortium Pitie Salpetriere Hospital, Necker Hospital, Paris, France
Search for other papers by Sophie Dubreuil in
Google Scholar
PubMed
EndoERN, APHP Consortium Pitie Salpetriere Hospital, Necker Hospital, Paris, France
Sorbonne University, Paris, France
Search for other papers by Philippe Touraine in
Google Scholar
PubMed
://doi.org/10.1016/j.fertnstert.2004.03.026 ) 16 Wirén L Boguszewski CL Johannsson G . Growth hormone (GH) replacement therapy in GH-deficient women during pregnancy . Clinical Endocrinology 2002 57 235 – 239 . ( https://doi.org/10.1046/j.1365
Search for other papers by Patrizia Bruzzi in
Google Scholar
PubMed
Search for other papers by Silvia Vannelli in
Google Scholar
PubMed
Search for other papers by Emanuela Scarano in
Google Scholar
PubMed
Search for other papers by Natascia Di Iorgi in
Google Scholar
PubMed
Search for other papers by Maria Parpagnoli in
Google Scholar
PubMed
Search for other papers by MariaCarolina Salerno in
Google Scholar
PubMed
Search for other papers by Marco Pitea in
Google Scholar
PubMed
Search for other papers by Maria Elisabeth Street in
Google Scholar
PubMed
Search for other papers by Andrea Secco in
Google Scholar
PubMed
Search for other papers by Adolfo Andrea Trettene in
Google Scholar
PubMed
Search for other papers by Malgorzata Wasniewska in
Google Scholar
PubMed
Search for other papers by Nicola Corciulo in
Google Scholar
PubMed
Search for other papers by Gianluca Tornese in
Google Scholar
PubMed
Search for other papers by Maria Felicia Faienza in
Google Scholar
PubMed
Search for other papers by Maurizio Delvecchio in
Google Scholar
PubMed
Search for other papers by Simona Filomena Madeo in
Google Scholar
PubMed
Search for other papers by Lorenzo Iughetti in
Google Scholar
PubMed
affecting the SHOX-coding region ( 8 ). Recombinant human growth hormone (rhGH) therapy is already approved for use in patients with SHOX-D in the USA, Europe and other countries ( 9 ), and it seems to have a growth-promoting activity similar to patients
Search for other papers by María Dolores Rodríguez Arnao in
Google Scholar
PubMed
Search for other papers by Amparo Rodríguez Sánchez in
Google Scholar
PubMed
Search for other papers by Ignacio Díez López in
Google Scholar
PubMed
Search for other papers by Joaquín Ramírez Fernández in
Google Scholar
PubMed
Search for other papers by Jose Antonio Bermúdez de la Vega in
Google Scholar
PubMed
Search for other papers by Diego Yeste Fernández in
Google Scholar
PubMed
Search for other papers by María Chueca Guindulain in
Google Scholar
PubMed
Search for other papers by Raquel Corripio Collado in
Google Scholar
PubMed
Search for other papers by Jacobo Pérez Sánchez in
Google Scholar
PubMed
Search for other papers by Ana Fernández González in
Google Scholar
PubMed
Search for other papers by ECOS Spain Study Collaborative Investigator Group in
Google Scholar
PubMed
pathologies) and in sensitivity to the hormone ( 4 ). Treatment with r-hGH has been shown to be effective in children and adolescents with GHD, increasing short-term growth and adult height ( 5 , 6 ). GH therapy requires daily subcutaneous injections for long
Search for other papers by Charlotte Höybye in
Google Scholar
PubMed
Search for other papers by Andreas F H Pfeiffer in
Google Scholar
PubMed
Search for other papers by Diego Ferone in
Google Scholar
PubMed
Search for other papers by Jens Sandahl Christiansen in
Google Scholar
PubMed
Search for other papers by David Gilfoyle in
Google Scholar
PubMed
Search for other papers by Eva Dam Christoffersen in
Google Scholar
PubMed
Search for other papers by Eva Mortensen in
Google Scholar
PubMed
Search for other papers by Jonathan A Leff in
Google Scholar
PubMed
Search for other papers by Michael Beckert in
Google Scholar
PubMed
and 70 years with a body mass index (BMI) of 19.0–36.0 kg/m 2 ) diagnosed with AGHD (defined according to the Growth Hormone Research Society Consensus Guidelines of 1998 and 2007) ( 1 , 12 ) who were stable on GH replacement therapy for at least 3
Search for other papers by Werner F Blum in
Google Scholar
PubMed
Search for other papers by Abdullah Alherbish in
Google Scholar
PubMed
Search for other papers by Afaf Alsagheir in
Google Scholar
PubMed
Search for other papers by Ahmed El Awwa in
Google Scholar
PubMed
Search for other papers by Walid Kaplan in
Google Scholar
PubMed
Search for other papers by Ekaterina Koledova in
Google Scholar
PubMed
Search for other papers by Martin O Savage in
Google Scholar
PubMed
Introduction The growth hormone (GH)–insulin-like growth factor (IGF)-I axis is the principle endocrine system regulating linear growth in children ( 1 ). Linked to the nutritional status of the individual, GH is a potent stimulator of IGF
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
School of Nursing and Midwifery, Institute of Clinical Sciences, University of Birmingham, UK
Search for other papers by Sherwin Criseno in
Google Scholar
PubMed
Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Search for other papers by Helena Gleeson in
Google Scholar
PubMed
Search for other papers by Andrew A Toogood in
Google Scholar
PubMed
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Search for other papers by Neil Gittoes in
Google Scholar
PubMed
Search for other papers by Anne Topping in
Google Scholar
PubMed
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Department of Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
Search for other papers by Niki Karavitaki in
Google Scholar
PubMed
2006 155 61 – 71 . ( https://doi.org/10.1530/eje.1.02191 ) 3 Johannsson G & Ragnarsson O . Growth hormone deficiency in adults with hypopituitarism are – what are the risks and can they be eliminated by therapy? Journal of Internal Medicine
Search for other papers by Chan Sub Park in
Google Scholar
PubMed
Search for other papers by Jihye Choi in
Google Scholar
PubMed
Search for other papers by Min-Ki Seong in
Google Scholar
PubMed
Search for other papers by Sung-Eun Hong in
Google Scholar
PubMed
Search for other papers by Jae-Sung Kim in
Google Scholar
PubMed
Search for other papers by In-Chul Park in
Google Scholar
PubMed
Search for other papers by Hyesil Seol in
Google Scholar
PubMed
Search for other papers by Woo Chul Noh in
Google Scholar
PubMed
Search for other papers by Hyun-Ah Kim in
Google Scholar
PubMed
has a beneficial effect on reducing cerebrovascular events in healthy postmenopausal women. However, concerning the breast cancer, the excess exposure to the high level of estradiol such as has long-term hormone replacement therapy, early menarche
Search for other papers by M Ahmid in
Google Scholar
PubMed
Search for other papers by C G Perry in
Google Scholar
PubMed
Search for other papers by S F Ahmed in
Google Scholar
PubMed
Search for other papers by M G Shaikh in
Google Scholar
PubMed
Dunger DB Cheetham TD Savage MO Monson JP. The effect of cessation of growth hormone (GH) therapy on bone mineral accretion in GH-deficient adolescents at the completion of linear growth . Journal of Clinical Endocrinology